SOXC Transcription Factors
"SOXC Transcription Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of closely-related SOX transcription factors. Members of the group have been found expressed in developing neuronal tissue, LYMPHOCYTES, and during EMBRYONIC DEVELOPMENT.
Descriptor ID |
D055751
|
MeSH Number(s) |
D12.776.260.719.300 D12.776.660.235.400.750.300 D12.776.664.235.400.750.300 D12.776.930.823.300
|
Concept/Terms |
SOX4 Transcription Factor- SOX4 Transcription Factor
- Transcription Factor, SOX4
- SOX-4 Transcription Factor
- SOX 4 Transcription Factor
- Transcription Factor, SOX-4
SOX12 Transcription Factor- SOX12 Transcription Factor
- Transcription Factor, SOX12
- SOX-12 Transcription Factor
- SOX 12 Transcription Factor
- Transcription Factor, SOX-12
SOX11 Transcription Factor- SOX11 Transcription Factor
- Transcription Factor, SOX11
- SOX-11 Transcription Factor
- SOX 11 Transcription Factor
- Transcription Factor, SOX-11
|
Below are MeSH descriptors whose meaning is more general than "SOXC Transcription Factors".
Below are MeSH descriptors whose meaning is more specific than "SOXC Transcription Factors".
This graph shows the total number of publications written about "SOXC Transcription Factors" by people in this website by year, and whether "SOXC Transcription Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "SOXC Transcription Factors" by people in Profiles.
-
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer. Br J Cancer. 2024 Jul; 131(1):171-183.
-
SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma? Mod Pathol. 2024 Feb; 37(2):100405.
-
From the archives of MD Anderson Cancer Center: Sporadic Burkitt lymphoma with a complex karyotype and SOX11 expression. Ann Diagn Pathol. 2023 Oct; 66:152182.
-
SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma. Arch Pathol Lab Med. 2023 07 01; 147(7):758-766.
-
Utility of SOX11 for the diagnosis of solid pseudopapillary neoplasm of the pancreas on cytological preparations. Cytopathology. 2022 03; 33(2):216-221.
-
Integrin av?6-TGF?-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer. Cancer Cell. 2021 01 11; 39(1):54-67.e9.
-
SOX11 and SOX4 drive the reactivation of an embryonic gene program during murine wound repair. Nat Commun. 2019 09 06; 10(1):4042.
-
Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma. Blood. 2019 01 24; 133(4):306-318.
-
Sox4 Promotes Atoh1-Independent Intestinal Secretory Differentiation Toward Tuft and Enteroendocrine Fates. Gastroenterology. 2018 11; 155(5):1508-1523.e10.
-
CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course. Mod Pathol. 2018 02; 31(2):327-336.